Target intelligence / Profile preview

Host proteases responsible for F0 cleavage

Molecular classification
Enzyme, Protease, Serine protease, Proprotein convertase
01

Overview

Host proteases responsible for F0 cleavage are a group of cellular enzymes, primarily including Furin and various Type II transmembrane serine proteases (TTSPs) like TMPRSS2, that are essential for the infectivity of many enveloped viruses (PubMed, PMID: 25135993). In viruses such as Respiratory Syncytial Virus (RSV) and other Paramyxoviruses, the fusion (F) protein is synthesized as an inactive F0 precursor that must be proteolytically processed into the disulfide-linked F1 and F2 subunits to become fusion-competent (UniProt, P03420). This cleavage event, often occurring at polybasic or monobasic motifs, exposes the fusion peptide, allowing the virus to merge its envelope with the host cell membrane (PubMed, PMID: 32155441). Because this process is strictly dependent on host machinery, these proteases represent attractive therapeutic targets for antiviral intervention, as seen with the use of serine protease inhibitors like camostat (PubMed, PMID: 32155441). Inhibiting these enzymes can effectively block viral entry and spread within the host. However, since these proteases also process vital endogenous proteins like growth factors and hormones, achieving therapeutic selectivity to avoid systemic toxicity remains a significant challenge (PubMed, PMID: 22508921).

Other names
F0-activating proteasesProprotein convertasesType II transmembrane serine proteasesFurin-like proteasesViral fusion protein processing enzymes
02

Mechanism of action

Inhibition of host-mediated proteolytic cleavage of the viral F0 precursor protein into F1 and F2 subunits, thereby preventing the conformational changes required for viral-cell membrane fusion and subsequent viral entry.

03

Biological functions

ProteolysisProtein processingViral entryMembrane fusion
04

Disease associations

InfectionRespiratory syncytial virus infectionParainfluenza virus infectionMeaslesInfluenza
05

Safety considerations

Interference with endogenous substrate processingPotential for systemic toxicityInhibition of physiological proprotein activation (e.g., growth factors, hormones)
06

Interacting drugs

Camostat mesylate

4 more in the full profile.

07

Biomarkers

Viral loadProtease expression levels in airway epitheliumF1/F2 subunit ratio

Beyond the preview

Go deeper on Host proteases responsible for F0 cleavage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host proteases responsible for F0 cleavage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call